The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Friday, December 06, 2019
CicloMed announced the expansion of its fosciclopirox clinical development program. The fosciclopirox first-in-human Phase 1 trial has been expanded ...
read more
Thursday, December 05, 2019
Bayer has announced a collaboration agreement with CHOP for the discovery and development of SMOLs to develop a NRT for the treatment of hemophilia A ...
read more
Wednesday, December 04, 2019
Rafael Pharmaceuticals announced the expansion of its Phase 2 clinical trial of CPI-613® (devimistat) for patients with relapsed or refractory Burkitt...
read more
Wednesday, December 04, 2019
SK Life Science announced that the FDA has accepted its IND application for SKL24741 for epilepsy.
read more
Wednesday, December 04, 2019
Cara Therapeutics announced positive topline results from its Phase 2 dose-ranging trial of Oral KORSUVA for pruritus in patients with stage III-V ...
read more
Tuesday, December 03, 2019
Orchard Therapeutics announced the European Medicines Agency has validated the company’s MAA for OTL-200.
read more
Monday, December 02, 2019
Mylan and Biocon announced the U.S. launch of Ogivri™ (trastuzumab-dkst), a biosimilar to Herceptin® (trastuzumab).
read more
Wednesday, November 27, 2019
The China NMPA approved a NDA for XTANDI® (enzalutamide) for adult men with metastatic castration-resistant prostate cancer.
read more
Wednesday, November 27, 2019
Usona Institute has received Breakthrough Therapy Designation from the FDA for psilocybin in the treatment of major depressive disorder.
read more
Wednesday, November 27, 2019
Sunovion announced the resubmission of the NDA to the FDA for apomorphine sublingual film to treat motor fluctuations.
read more
Wednesday, November 27, 2019
Verrica announced its NDA for VP-102, a proprietary topical therapy for the treatment of molluscum contagiosum, has been accepted for filing by the ...
read more
Tuesday, November 26, 2019
Phoenix Molecular Designs has dosed the first patient in its Phase 1/1b study of PMD-026, the company's lead product candidate.
read more
Tuesday, November 26, 2019
The FDA granted accelerated approval to Oxbryta (voxelotor) for the treatment of sickle cell disease in adults and pediatric patients 12 years of age ...
read more
Monday, November 25, 2019
Orchard Therapeutics announced the CHMP of the EMA has granted an accelerated assessment for OTL-200 for the treatment of metachromatic leukodystrophy...
read more
Monday, November 25, 2019
The FDA has authorized the advancement of Plenitude, the company’s clinical trial for its investigational therapeutic QIXLEEF for uncontrolled pain in...
read more